BioElectronics Announces Drug Free, Anti Inflammatory Sports Medicine Patch
Posted on: Tuesday, 12 June 2007, 10:53 CDT
FREDERICK, Md., June 12 /PRNewswire-FirstCall/ -- BioElectronics Corporation, (Pink Sheets: BIEL), is the maker and world wide distributor of the drug free anti-inflammatory ActiPatch(TM). ActiPatch(TM) is an inexpensive over the-counter, home therapy that is ideal to relieve pain and swelling and accelerate healing in soft tissue injuries without the use of oral non- steroidal anti-inflammatory drugs (NSAIDs) or external analgesics found in most hot cold therapies and other pain relief patches.
"We are excited about the many sports and work related injury applications and the additional market potential for the cardiovascular and kidney patients that are at significant risk using other analgesics. We are conducting additional clinical trials and studies to expand the indications of use for ActiPatch therapy," said Andrew J. Whelan, President and CEO.
ActiPatch(TM) Therapy is an embedded battery operated microchip that delivers 720 hours of pulsed therapy for only a few cents per hour. Pulsed electromagnetic therapy has been used by physicians and other therapists in offices and clinics for decades to relive pain, swelling and accelerate healing. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly home therapy.
BioElectronics Corporation is a medical device company focused on the design and development of market disruptive, disposable, and inexpensive, pulsed electromagnetic therapies. The Company is ISO certified with US FDA, Canadian, and European Union market clearances.
For more information visit http://www.bioelectronicscorp.com/ Safe Harbor Statement:
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
BioElectronics Corporation
CONTACT: Andrew J. Whelan, President & CEO of BioElectronicsCorporation, +1-301-644-3906, fax, +1-301-644-3937,info@bioelectronicscorp.com
Web site: http://www.bioelectronicscorp.com/
Source: PRNewswire-FirstCall
Related Articles
- Exercise Therapy Best For Knee Pain
- Chronic Pain Drug Market Will Experience Modest Four Percent Annual Growth From 2008 to 2018
- Social Media and Corporate Marketing: Is it Hype or is it Here?
- Apple iPhone Making Inroads Into Corporate Market
- Gene Therapy May Stop Arthritis Pain
- Visible Technologies Names D. Blake Cahill Vice President of Corporate Marketing
- Cadence Appoints New Vice President of Corporate Marketing
- Market Pulse Announces Corporate Profile on BioElectronics Corporation
- Trident Announces New Vice President of Worldwide Business Development and Corporate Marketing
- Terayon and Axerra Enable Cable Operators to Serve Lucrative Corporate Market With the FLEXable Commercial Services Solution
 |
 |
User Comments (0)
RSS Feeds